Cargando…
Overexpression of SEZ6L2 predicts poor prognosis in patients with cholangiocarcinoma
BACKGROUND: With the feature of destructive and biliary malignancy, intrahepatic cholangiocarcinoma (ICC), presents unclear molecular mechanisms which contributes to typically poor prognosis for patients. Seizure-related 6 homolog-like 2 (SEZ6L2) is a gene that encodes for a seizure-associated prote...
Autores principales: | Wang, Ziming, Lai, Jiaming, Liang, Lijian, Yin, Xiaoyu, Wang, Qian, Cheng, Quanyong, Zheng, Chaoxu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798643/ https://www.ncbi.nlm.nih.gov/pubmed/35117286 http://dx.doi.org/10.21037/tcr-20-1527 |
Ejemplares similares
-
BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains
por: Causevic, Mirsada, et al.
Publicado: (2018) -
Identification of SMIM1 and SEZ6L2 as Potential Biomarkers for Genes Associated with Intervertebral Disc Degeneration in Pyroptosis
por: Wang, Nan, et al.
Publicado: (2022) -
SEZ6L2 Antibody–Associated Cerebellar Ataxia Responsive to Sequential Immunotherapy
por: Mehdiyeva, Ayla, et al.
Publicado: (2022) -
SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Ning, Shanglei, et al.
Publicado: (2018) -
SEZ6L2 knockdown impairs tumour growth by promoting caspase‐dependent apoptosis in colorectal cancer
por: An, Ning, et al.
Publicado: (2020)